跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 279 条关于
“PARP2”
全部
279
临床试验
181
药物
54
机构
0
资讯
44
9天前
1cBio Licenses Preclinical PARP1 Inhibitor OC-3 to Lee's Pharm for Greater China and Southeast Asia in Deal Worth Up to $27 Million
2年前
Saruparib Shows Promise in HRR-Deficient Breast Cancer
去年
Saruparib Shows Promise as Selective PARP1 Inhibitor in Advanced Solid Tumors
2个月前
PARP Inhibitors Expand Beyond BRCA-Mutated Cancers: Emerging Evidence Across Solid Tumors and Combination Strategies
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
去年
ctDNA Analysis Reveals Mechanisms of PARP Inhibitor Resistance in Prostate Cancer
12年前
Niraparib Maintenance Therapy Demonstrates Sustained Benefit in Recurrent Ovarian Cancer
4年前
PARP Inhibitors Show Promise in Ovarian Cancer Maintenance Therapy
去年
PARP Inhibitor Niraparib Shows Breakthrough Results in Mesothelioma Treatment
第 1 页,共 5 页
上一页
下一页